Worthington v. GlaxoSmithKline LLC et al
Rachel Worthington |
GlaxoSmithKline LLC, GlaxoSmithKline (America) Inc., GlaxoSmithKline PLC, Pfizer Inc., L. Perrigo Company, Ranbaxy, Inc., Sandoz, Inc., Sun Pharmaceutical Industries, Inc. and Teva Pharmaceuticals USA, Inc. |
3:2023cv20229 |
March 26, 2023 |
US District Court for the Southern District of Florida |
Personal Inj. Prod. Liability |
28 U.S.C. ยง 1332 Diversity-Product Liability |
Plaintiff |
Docket Report
This docket was last retrieved on March 26, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 1 COMPLAINT against GlaxoSmithKline (America) Inc., GlaxoSmithKline LLC, GlaxoSmithKline PLC, L. Perrigo Company, Pfizer Inc., Ranbaxy, Inc., Sandoz, Inc., Sun Pharmaceutical Industries, Inc., Teva Pharmaceuticals USA, Inc.. Filing fees $ 402.00 receipt number AFLSDC-16467955, filed by Rachel Worthington. (Attachments: #1 Civil Cover Sheet)(Flaherty, Yvonne) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Florida Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.